| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 05/10/2011 | US7939061 Cell and enzyme compositions for modulating bile acids, cholesterol and triglycerides |
| 05/10/2011 | US7938641 Extrusion die |
| 05/10/2011 | CA2614746C Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes |
| 05/10/2011 | CA2519063C Immunomodulating heterocyclic compounds |
| 05/10/2011 | CA2494208C N-aryl piperidine substituted biphenylcarboxamides as inhibitors of apolipoprotein b secretion |
| 05/10/2011 | CA2483105C Autoimmune conditions and nadph oxidase defects |
| 05/10/2011 | CA2478335C Amino-methyl substituted tetracycline compounds |
| 05/10/2011 | CA2475498C Piperidine derivative and pharmaceutical composition comprising the same as active ingredient |
| 05/10/2011 | CA2418815C Polysaccharides with antithrombotic activity comprising at least a covalent bond with biotin or a biotin derivative |
| 05/10/2011 | CA2417806C New immunoeffector compounds |
| 05/10/2011 | CA2363712C Long lasting insulinotropic peptides |
| 05/05/2011 | WO2011053994A1 Modulation of ldl receptor gene expression with double-stranded rnas targeting the ldl receptor gene promoter |
| 05/05/2011 | WO2011053822A2 Notch inhibition in the treatment and prevention of obesity and metabolic syndrome |
| 05/05/2011 | WO2011053821A1 Macrocyclic ghrelin receptor antagonists and inverse agonists and methods of using the same |
| 05/05/2011 | WO2011052935A2 Composition for lowering blood sugar, comprising extract of smilax chine l., momordica charantia and cordyceps militaris as active ingredient |
| 05/05/2011 | WO2011052756A1 Novel 3-hydroxy-5-arylisoxazole derivative |
| 05/05/2011 | WO2011052523A1 Glycosylated form of antigenic glp-1 analogue |
| 05/05/2011 | WO2011051961A1 Compounds for the treatment of dyslipidemia and related diseases |
| 05/05/2011 | WO2011051899A1 A synergistic composition of (-)-hydroxycitric acid with monoterpene and a method to enhance satiety |
| 05/05/2011 | WO2011051864A1 Dioxa-bicyclo[3.2.1]octane-2,3,4-triol derivatives |
| 05/05/2011 | WO2011051486A2 Pharmaceutical solution of non covalently bound albumin and acylated insulin |
| 05/05/2011 | WO2011051478A1 Novel oxime derivatives and their use as allosteric modulators of metabotropic glutamate receptors |
| 05/05/2011 | WO2011051357A1 Therapeutic gas for the treatment of mitochondrial disorders |
| 05/05/2011 | WO2011051346A1 Composition to induce specific immune tolerance |
| 05/05/2011 | WO2011051342A1 IMIDAZO[1,2-b]PYRIDAZINE DERIVATIVES AND THEIR USE AS PDE10 INHIBITORS |
| 05/05/2011 | WO2011051289A1 Active ingredient product |
| 05/05/2011 | WO2011050474A1 Concentrated therapeutic phospholipid compositions |
| 05/05/2011 | WO2011011302A3 Differentiation of human embryonic stem cells |
| 05/05/2011 | WO2010151565A3 Combination therapies for the treatment of obesity |
| 05/05/2011 | WO2010151503A3 Combination therapies for the treatment of obesity |
| 05/05/2011 | WO2010147830A3 Aminothiazole modulators of beta-3-adrenoreceptor |
| 05/05/2011 | WO2010147430A3 Novel c-aryl glucoside sglt2 inhibitors and pharmaceutical composition comprising same |
| 05/05/2011 | WO2010146568A3 Bifidobacteria for treating diabetes and related conditions |
| 05/05/2011 | WO2010031248A8 Thiazolium salt compound and the use of treating the protein aging disease |
| 05/05/2011 | US20110107443 Novel protein transduction domains derived from secretory leukocyte protease inhibitor |
| 05/05/2011 | US20110105748 Novel beta-phenyl-alpha-oxysubstituted propionic derivatives: process for its preparation and their use in the preparation of pharmaceutically important compounds |
| 05/05/2011 | US20110105616 Novel lysine salts of 4-((phenoxyalkyl)thio)-phenoxyacetic acid derivatives |
| 05/05/2011 | US20110105606 Compositions and methods affecting the signaling pathways of LRP receptors |
| 05/05/2011 | US20110105600 Synergistic composition of (-)-hydroxycitric acid with monoterpene and a method to enhance satiety |
| 05/05/2011 | US20110105575 Method of treatment of hereditary hemochromatosis |
| 05/05/2011 | US20110105573 Benzimidazole acetic acids exhibiting crth2 receptor antagonism and uses thereof |
| 05/05/2011 | US20110105555 Substituted n-imidazo[2,1-b]thiazole-5-sulfonamide derivatives as 5-ht6 ligands |
| 05/05/2011 | US20110105543 Novel triaryl derivatives useful as modulators of nicotinic acetylcholine receptors |
| 05/05/2011 | US20110105538 Drug response markers |
| 05/05/2011 | US20110105535 Inhibitors of phosphatidylinositol 3-kinase |
| 05/05/2011 | US20110105530 Organic compounds |
| 05/05/2011 | US20110105527 Pyrazines as delta opioid receptor modulators |
| 05/05/2011 | US20110105526 Selective subtype alpha 2 adrenergic agents and methods for use thereof |
| 05/05/2011 | US20110105508 Quinoxaline and quinoline derivatives as kinase inhibitors |
| 05/05/2011 | US20110105505 Thiazolyl piperidine derivatives |
| 05/05/2011 | US20110105499 Pyrazolo-Pyrazinone Compounds and Methods of Use Thereof |
| 05/05/2011 | US20110105498 Pyrazolo-pyridinone and pyrazolo-pyrazinone compounds as P38 modulators and methods of use thereof |
| 05/05/2011 | US20110105496 Methods For The Treatment Of Myosin Heavy Chain-Mediated Conditions Using 4,7-Dihydrothieno[2,3-B]Pyridine Compounds |
| 05/05/2011 | US20110105486 Thiazole derivatives |
| 05/05/2011 | US20110105478 Novel 1,4-diaza-bicyclo[3.2.2]nonyl oxadiazolyl derivatives useful as modulator of nicotinic acetylcholine receptors |
| 05/05/2011 | US20110105464 Phosphoinositide 3-kinase inhibitor compounds and methods of use |
| 05/05/2011 | US20110105462 Modulators of dopamine neurotransmission |
| 05/05/2011 | US20110105461 Modulators of dopamine neurotransmission |
| 05/05/2011 | US20110105460 Triazole derivative or salt thereof |
| 05/05/2011 | US20110105459 Azetidines and cyclobutanes as histamine h3 receptor antagonists |
| 05/05/2011 | US20110105458 Fatty acid inhibitors |
| 05/05/2011 | US20110105452 Oxidant Scavengers for Treatment of Diabetes or Use in Transplantation or Induction of Immune Tolerance |
| 05/05/2011 | US20110105447 Novel modulators of calcium release-activated calcium channel |
| 05/05/2011 | US20110105444 Once-a-week administration of 25-hydroxy vitamin d3 to sustain elevated steady-state pharmacokinetic blood concentration |
| 05/05/2011 | US20110105440 HEXAHYDROCYCLOPENTYL[f]INDAZOLE SULFONAMIDES AND DERIVATIVES THEREOF AS SELECTIVE GLUCOCORTICOID RECEPTOR MODULATORS |
| 05/05/2011 | US20110105427 Deazapurines and uses thereof |
| 05/05/2011 | US20110105424 Glucopyranoside compound |
| 05/05/2011 | US20110105420 Aminosugar compound and process for production thereof |
| 05/05/2011 | US20110105419 Pharmacological adjuvants based on coordination compounds of d-metals |
| 05/05/2011 | US20110105403 Peptides |
| 05/05/2011 | US20110105394 Amylin Derivatives |
| 05/05/2011 | US20110105392 Pegylated Insulin Lispro Compounds |
| 05/05/2011 | US20110105391 Methods and Compositions for Delivering Peptides |
| 05/05/2011 | US20110105389 Macrocyclic Ghrelin Receptor Antagonists and Inverse Agonists and Methods of Using the Same |
| 05/05/2011 | US20110105379 Saccharide-containing protein conjugates and uses thereof |
| 05/05/2011 | US20110104315 Tetrahydroquinoline derivatives as cannabinoid receptor modulators |
| 05/05/2011 | US20110104314 Aloe vera extract, method of producing aloe vera extract, and hyperglycemia improving agent |
| 05/05/2011 | US20110104310 Method of Manufacturing Magnoliidae Compounds |
| 05/05/2011 | US20110104308 Treatment For Diseases Relying On Discovery That Thioredoxin Mediates Nitric Oxide |
| 05/05/2011 | US20110104297 Methods of using krill oil to treat risk factors for cardiovascular, metabolic, and inflammatory disorders |
| 05/05/2011 | US20110104296 Endorphin Therapy Compositions and Methods |
| 05/05/2011 | US20110104290 Compositions for reducing blood glucose level and uses thereof |
| 05/05/2011 | US20110104277 Oxygen barrier film coatings for pharmaceutical dosage forms |
| 05/05/2011 | US20110104263 Claudin-4 binding peptides, compositions and methods of use |
| 05/05/2011 | US20110104219 Denture care composition |
| 05/05/2011 | US20110104206 Methods and compositions for sustained delivery of drugs |
| 05/05/2011 | US20110104189 Compositions obtained from chlorella extract having immunomodulating properties |
| 05/05/2011 | US20110104187 Method of treating glygogen storage disease |
| 05/05/2011 | US20110104173 Inhibition of degradation of extracellular matrix |
| 05/05/2011 | US20110104167 Compositions and Methods for Diagnosing and Treating Insulin Resistance |
| 05/05/2011 | US20110104156 Methods and materials for treating autoimmune and/or complement mediated diseases and conditions |
| 05/05/2011 | US20110104152 Chimeric fibroblast growth factors with altered receptor specificity |
| 05/05/2011 | US20110104137 ADJUNCTS AND COMPLEXES FOR IMPROVING HMG-CoA REDUCTASE INHIBITOR (STATIN) AND SELECTIVE PHOSPHODIESTERASE 5 INHIBITOR THERAPY |
| 05/05/2011 | US20110104133 Methods and compositions for inducing brown adipogenesis |
| 05/05/2011 | US20110104130 Thymidylate kinase fusions and uses thereof |
| 05/05/2011 | US20110104125 Episomal reprogramming with chemicals |
| 05/05/2011 | US20110104119 Chimeric Vectors |
| 05/05/2011 | US20110104114 Polysaccharide-Protein Conjugates Reversibly Coupled Via Imine Bonds |
| 05/05/2011 | US20110104102 Method for stimulating mammalian cells and mammalian cell |
| 05/05/2011 | US20110104078 Uv absorbing complex polyester polymers, compositions containing uv absorbing complex polyester polymers, and related methods |